Biotech Specialty Pharma


3000 Bayport Dr
Tampa, FL 33607 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Oragenics develops novel products and diagnostics.

Management Michael Sullivan, Chief Financial Officer; Jefferey Hillman, CSO; Gerry David, Executive Vice President; Dr. John Bonfiglio, Chief Executive Officer and President; Dr. Martin Handfield, Vice President of Research

Click here for Financial Data
Keywords: replacement therapy, antibiotic, infectuous disease, oral probiotic, Dental, Infectious Disease, head and neck, oral mucositis


Updated: Apr. 14, 2018


Oragenics is a biopharmaceutical company focused primarily on oral health products and novel antibiotics. Within oral health, the company is developing a pharmaceutical product candidate, SMaRT Replac......view more

Products / Services

Replacement Therapy is a single, painless topical treatment that has the potential to offer life-long protection from most tooth decay. They expect to initiate Phase I clinical safety trials with this......view more

Technology / Differentiation

Genetically modified strains of bacteria including S. mutans; Probiotics; gene target identification; Lantibiotics....view more